Cancer medicines

Articles

• 
  Economy

  Cancer Drug Trade Margins Capped at 30 Per Cent of MRP

  The Government has capped margins on non-scheduled anti-cancer medicines at 30 per cent of MRP, a step expected to save patients Rs 2,500 crore a year.

  8 October 2026 · 2 min read